BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andres SF, Williams KN, Rustgi AK. The Molecular Basis of Metastatic Colorectal Cancer. Curr Colorectal Cancer Rep 2018;14:69-79. [PMID: 30237756 DOI: 10.1007/s11888-018-0403-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Li X. Encorafenib inhibits migration, induces cell cycle arrest and apoptosis in colorectal cancer cells. Mol Cell Biochem 2019;459:113-20. [PMID: 31114933 DOI: 10.1007/s11010-019-03554-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Poturnajova M, Furielova T, Balintova S, Schmidtova S, Kucerova L, Matuskova M. Molecular features and gene expression signature of metastatic colorectal cancer (Review). Oncol Rep 2021;45:10. [PMID: 33649827 DOI: 10.3892/or.2021.7961] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Ma M, Li L, Chen H, Feng Y. Oxytocin Inhibition of Metastatic Colorectal Cancer by Suppressing the Expression of Fibroblast Activation Protein-α. Front Neurosci 2019;13:1317. [PMID: 31920487 DOI: 10.3389/fnins.2019.01317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Andres SF, Williams KN, Plesset JB, Headd JJ, Mizuno R, Chatterji P, Lento AA, Klein-Szanto AJ, Mick R, Hamilton KE, Rustgi AK. IMP1 3' UTR shortening enhances metastatic burden in colorectal cancer. Carcinogenesis 2019;40:569-79. [PMID: 30407516 DOI: 10.1093/carcin/bgy153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]